Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 4 Shares withheld for taxes EVP Glob. Prod Strat and Comm gave up 940 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP, Human Resources gave up 2,182 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP Pharmaceutical Oper & Tech gave up 715 shares (to pay taxes)
  4. 4 Shares withheld for taxes EVP Chief Legal Off & Corp Sec gave up 3,896 shares (to pay taxes)
  5. 4 Open-market buy Director bought 898 shares at $267.00 ($239,766)
  6. 5 Insider Annual Insider Trading Report
  7. 5 Insider Annual Insider Trading Report
  8. 4 Grant or award EVP Chief Legal Off & Corp Sec acquired 4,545 shares (grant or award)
  9. 4 Grant or award EVP Pharmaceutical Oper & Tech acquired 818 shares (grant or award)
  10. 4 Grant or award EVP, Human Resources acquired 2,558 shares (grant or award)
  11. 4 Grant or award EVP, Research & Development acquired 3,728 shares (grant or award)
  12. 4 Grant or award Chief Executive Officer acquired 16,343 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 22 shares (to pay taxes)
  15. 4 Shares withheld for taxes EVP Glob. Prod Strat and Comm gave up 562 shares (to pay taxes)
  16. 4 Open-market buy Chief Executive Officer bought 3,100 shares at $241.31 ($748,047)
  17. 4 Open-market sale EVP, Research & Development sold 1,500 shares at $350.00 ($525,000)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 15 of 86 · 1,714 filings